Comparison of Risk of Pneumonia Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study-Reference-Cited by-同舟云学术

Comparison of Risk of Pneumonia Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study

Published:2021-11 Issue: Volume:Volume 16 Page:3229-3237
ISSN:1178-2005
Container-title:International Journal of Chronic Obstructive Pulmonary Disease
language:en
Short-container-title:COPD

Author:

Choi Jae-Hwa,Jeong Keun-Bae^ORCID,Park You Hyun^ORCID,Yu Iseul,Lee Seok Jeong,Lee Myoung Kyu^ORCID,Kim Sang-Ha^ORCID,Lee Won-Yeon^ORCID,Yong Suk Joong,Lee Ji-Ho^ORCID

Publisher

Informa UK Limited

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pulmonary and Respiratory Medicine,General Medicine

Reference35 articles.

1. Direct and Indirect Costs of Chronic Obstructive Pulmonary Disease in Korea

2. Pharmacology and Therapeutics of Bronchodilators Revisited

3. Blood Eosinophil Counts in Chronic Obstructive Pulmonary Disease: A Biomarker of Inhaled Corticosteroid Effects

4. Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD

5. Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intraclass comparison of inhaled corticosteroids for the risk of pneumonia in chronic obstructive pulmonary airway disorder: a network meta-analysis and meta-regression;International Journal of Clinical Pharmacy;2024-04-25

2. A Case of Obstructing Bronchial Aspergillosis in a Patient Receiving Cytotoxic Chemotherapy and Inhaled Corticoid Therapy;Respiratory Endoscopy;2023-11-29

3. Exploring the appropriateness of prescribing practice of inhaled pharmacotherapy among Aboriginal Australians in the Top End Northern Territory of Australia: a retrospective cohort study;BMJ Open Respiratory Research;2023-03

4. A Case of Obstructing Bronchial Aspergillosis in a Patient Receiving Cytotoxic Chemotherapy and Inhaled Corticoid Therapy;2023-01-24

5. May a different kinetic mode explain the high efficacy/safety profile of inhaled budesonide?;Pulmonary Pharmacology & Therapeutics;2022-12